about
Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)Prescribed therapy for asthma: therapeutic ratios and outcomes.Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC.Erratum to: Prescribed therapy for asthma: therapeutic ratios and outcomes.Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012Alcohol consumption over time and mortality in the Swedish Women's Lifestyle and Health cohort.Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study.Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study.Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study.Physical activity and risk of endometrial cancer in the Norwegian Women and Cancer (NOWAC) study.Sex Differences in Risk of Smoking- Associated Lung Cancer: Results From a Cohort of 600,000 Norwegians.Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study.F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.Fruit and vegetable intake and cause-specific mortality in the EPIC study.[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey].Lifetime number of years of menstruation as a risk index for postmenopausal endometrial cancer in the Norwegian Women and Cancer StudyCoffee Drinking and the Risk of Endometrial Cancer: An Updated Meta-Analysis of Observational StudiesRisk of lung cancer and physical activity by smoking status and body mass index, the Norwegian Women and Cancer StudyWhy harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancerImpact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K studyExcess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer studyProspective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncologyStereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug groupÉtude observationnelle sur l’adhésion précoce aux traitements hypotonisants anti-glaucomateux
P50
Q26256419-0B9E3C99-FAD8-47BF-BD3E-EA9EE70FEF78Q35534302-D5A1968C-9F65-4521-85C5-FA0D9E34EC35Q35746368-95AEDCD6-21E1-4535-8EC5-190FAD85C3AFQ35904135-49ADE85F-0256-46E2-9687-3EBDF7C83435Q36797302-5BF41AE1-1615-481C-A783-7AB1BBAC7BBEQ37455119-DFB4ACB3-82F5-4586-A802-37815976B714Q37592890-A7406344-E665-42A6-8095-EB7106083A00Q39266106-81F89E15-F777-4C34-9781-8286E2FDBFAEQ39891907-F21F42C5-2070-4206-84B9-4FF5401A90CAQ40129062-82C64D9E-BCEE-422C-92E5-09F533A7054DQ40370438-7E9454DC-E499-4A91-853B-1FBD8806F82FQ47684161-77C73E90-890E-425D-A83E-72585CA10DE5Q48308633-89DD1333-2604-4B58-BEE1-CCEBCCD67254Q48360682-23F0A261-C58D-4C28-A739-74AC7624316FQ50625963-C890BDE1-AC8D-47BB-9724-EF18224358BEQ51739682-FC550F50-29C0-4CC1-BC70-7A03E94EEFD3Q57025281-CD95E718-D8ED-4FF4-9273-8867081D72D7Q57025323-9E85500F-E4F7-4E5A-B305-7949A94A39EAQ57054907-F2D6A6D3-B4AB-4869-9186-B871DE040C3CQ57990669-2731DAA8-ECA3-4DF2-AE64-525F749D53E8Q58768203-D30A6D1F-480C-4804-8348-9ADDABF593D3Q60472171-C3B421C6-68A1-4F1F-AC7D-F2A0BEBDB7FBQ60472359-BEA7663A-E7DF-4ADE-873E-DA8E1641AAF2Q60472360-E3BD8171-D5A8-4308-A5B6-03B655D1C221Q60472363-1C545DCD-CC9D-404C-B29D-699E0577BB1B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Idlir Licaj
@ast
Idlir Licaj
@en
Idlir Licaj
@es
Idlir Licaj
@nl
type
label
Idlir Licaj
@ast
Idlir Licaj
@en
Idlir Licaj
@es
Idlir Licaj
@nl
altLabel
idlir licaj
@en
prefLabel
Idlir Licaj
@ast
Idlir Licaj
@en
Idlir Licaj
@es
Idlir Licaj
@nl
P106
P21
P31
P496
0000-0003-3389-0735